Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient’s IADL?
Sign Up to like & getrecommendations! Published in 2022 at "Neuro-Oncology Practice"
DOI: 10.1093/nop/npac016
Abstract: Abstract Background Neurocognitive impairments are common among brain tumor patients, and may impact patients’ awareness of performance in instrumental activities in daily life (IADL). We examined differences between patient- and proxy-reported assessments of the patient’s… read more here.
Keywords: patients proxies; brain tumor; neurocognitive impairments; tumor patients ... See more keywords